781 PK, EFFICACY AND SAFETY OF MIRIKIZUMAB AS INDUCTION THERAPY IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2 SHINE-1 STUDY
作者
Jess L. Kaplan,Athos Bousvaros,Dan Turner,Marla Cindy Dubinsky,Wendy J. Komocsar,Amy Larkin,Jordan Johns,Xin Zhang,Cheryl A. Little,Wallace Crandall,Vipin Arora,Jeffrey S. Hyams